Mainz Biomed B.V. (4TO.SG)

6.00 +0.13 (+2.28%) As of 08:02AM CET. Market open.

Mainz Biomed B.V.

Robert Koch Strasse 50
Mainz 55129
Germany
49 6131 554 2860
https://mainzbiomed.com

Sector(s): Healthcare
Industry: Diagnostics & Research
Full Time Employees: 

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Guido Baechler	CEO & Director	N/A	N/A	1965
Mr. William J. Caragol	Chief Financial Officer	N/A	N/A	1967
Mr. Philipp Freese	Chief Operating Officer	N/A	N/A	1983
Dr. Moritz Eidens Ph.D.	Chief Science Officer & Director	N/A	N/A	1984
Stefan Erlach	Head of HR	N/A	N/A	N/A
Mr. Darin S. Leigh	Chief Commercial Officer	N/A	N/A	N/A

Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.

Description

Mainz Biomed B.V., a molecular genetics cancer diagnostic company, develops in-vitro diagnostic (IVD) and research use only tests for clinical diagnostics in human genetics. It offers ColoAlert, a colorectal cancer screening test; PancAlert, a product candidate for a pancreatic cancer screening test; GenoStrip to detect pathogens in environments on a molecular genetic basis; and research-use-only and IVD tests. The company was founded in 2008 and is based in Mainz, Germany.

Corporate Governance

Mainz Biomed B.V.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.